ATLASAbbott Laboratories (ABT) earnings date: expected January 17–23
Abbott Laboratories (ABT) has not announced its next earnings date yet. Based on its last 4 reports, ATLAS expects it around January 17–23. That is an estimate, not a confirmed date.
Source: company filings and exchange data · Updated Nov 2, 2026
ATLAS view on ABT
| Last price | $106.20 (+1.6%) |
|---|---|
| Normal 1-day range (±1σ) | ±1.3% |
| Earnings beat history | Beat the EPS estimate in 2 of the last 6 reports |
| Dividend | $2.52 a year (2.37% yield) |
These figures come from the same calibrated model and valuation as the Abbott Laboratories stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.
Expected around January 17–23 (estimate). One email the day before, with ATLAS’s read on Abbott Laboratories. You can switch it off at any time.
Alert me before ABT reportsFree to start. Creating an account takes under a minute.
ABT earnings at a glance
| Next report | Not announced · expected around January 17–23 (ATLAS estimate) |
|---|---|
| Last report | Oct 21, 2026 · In line |
| Beat rate (last 6 reports) | 2 of 6 (33%) |
| Average EPS surprise | +1.5% |
| Average move around a report | ±5.7% (last 6) |
| Sector | Healthcare · Medical Devices |
The expected window is an ATLAS estimate: it takes the typical gap between Abbott Laboratories’s last 4 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.
Abbott Laboratories earnings history: last 6 reports
Abbott Laboratories last reported on Oct 21, 2026: EPS of $1.42 against an estimate of $1.43 (-0.7% surprise), in line with the estimate.
| Report date | EPS est. | EPS actual | Surprise | Result | Move* |
|---|---|---|---|---|---|
| Oct 21, 2026 | $1.43 | $1.42 | -0.7% | In line | +0.1% |
| Jul 16, 2026 | $1.28 | $1.31 | +2.3% | Beat | +12.8% |
| Apr 16, 2026 | $1.15 | $1.15 | 0.0% | In line | -4.7% |
| Jan 22, 2026 | $1.49 | $1.50 | +0.7% | In line | -11.0% |
| Oct 21, 2025 | $2.10 | $2.24 | +6.7% | Beat | -1.2% |
| Oct 15, 2025 | $1.30 | $1.30 | 0.0% | In line | -4.2% |
*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.
Get the full ATLAS analysis for ABT
See the fair value, the probability range and the earnings history of Abbott Laboratories on its ATLAS page.
Abbott Laboratories (ABT) stock analysisPlans from €3.99 a month.
Abbott Laboratories earnings: frequently asked questions
When is Abbott Laboratories (ABT) next earnings date?
Abbott Laboratories has not announced its next report. Its last 4 reports came Oct 21, 2026, Jul 16, 2026, Apr 16, 2026, Jan 22, 2026, so ATLAS estimates the next one around January 17–23. This is an estimate based on that pattern, not a confirmed date.
How often does ABT beat earnings estimates?
Of its last 6 reports with a recorded result, Abbott Laboratories beat the EPS estimate 2 times; the average surprise was +1.5%. Past results do not predict the next one.
How much does ABT move around earnings?
Over its last 6 reports the stock moved an average of 5.7% (absolute, from the close before the report day to the close after it), and finished higher 2 of 6 times.
Did Abbott Laboratories beat earnings estimates last quarter?
Abbott Laboratories last reported on Oct 21, 2026: EPS of $1.42 against an estimate of $1.43 (-0.7% surprise), in line with the estimate.
How much does ABT usually move in a day?
On a normal trading day the ATLAS model puts ABT’s one-day range at about ±1.3%, with a 51% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.
Educational information, not investment advice. Disclaimer